Bull Marta E, Legard Jillian, Tapia Kenneth, Sorensen Bess, Cohn Susan E, Garcia Rochelle, Holte Sarah E, Coombs Robert W, Hitti Jane E
*Department of Pediatrics, University of Washington, Seattle, WA; †Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA; ‡Department of Global Health, University of Washington, Seattle, WA; §Department of Medicine, University of Rochester Medical Center, Rochester, NY; Departments of ‖Pathology; ¶Medicine, University of Washington, Seattle, WA; #Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA; **Department of Laboratory Medicine, University of Washington, Seattle, WA; ††Department of Obstetrics and Gynecology, University of Washington, Seattle, WA (J. Legard is now with the Global Alliance to Prevent Prematurity and Stillbirth Program, Seattle Children's Hospital, Seattle, WA; B. Sorensen is now with Gilead, Seattle, WA; S. E. Cohn is now with the Department of Medicine, Northwestern University, Chicago, IL).
J Acquir Immune Defic Syndr. 2014 Dec 1;67(4):357-64. doi: 10.1097/QAI.0000000000000336.
HIV-1 shedding from the female genital tract is associated with increased sexual and perinatal transmission and has been broadly evaluated in cross-sectional studies. However, few longitudinal studies have evaluated how the immune microenvironment effects shedding.
Thirty-nine HIV-1-infected women had blood, cervicovaginal lavage, and biopsies of the uterine cervix taken quarterly for up to 5 years. Cytokines/chemokines were quantified by Luminex assay in cervicovaginal lavage, and cellular phenotypes were characterized using immunohistochemistry in cervical biopsies. Comparisons of cytokine/chemokine concentrations and the percent of tissue staining positive for T cells were compared using generalized estimating equations between non-shedding and shedding visits across all women and within a subgroup of women who intermittently shed HIV-1.
Genital HIV-1 shedding was more common when plasma HIV-1 was detected. Cytokines associated with cell growth (interleukin-7), Th1 cells/inflammation (interleukin-12p70), and fractalkine were significantly increased at shedding visits compared with non-shedding visits within intermittent shedders and across all subjects. Within intermittent shedders and across all subjects, FOXP3 T cells were significantly decreased at shedding visits. However, there were significant increases in CD8 cells and proportions of CD8FOXP3 T cells associated with HIV-1 shedding.
Within intermittent HIV-1 shedders, decreases in FOXP3 T cells at the shedding visit suggests that local HIV-1 replication leads to CD4 T-cell depletion, with increases in the proportion of CD8FOXP3 cells. HIV-1-infected cell loss may promote a cytokine milieu that maintains cellular homeostasis and increases immune suppressor cells in response to HIV-1 replication in the cervical tissues.
女性生殖道中的HIV-1脱落与性传播和围产期传播增加有关,并且在横断面研究中已得到广泛评估。然而,很少有纵向研究评估免疫微环境如何影响病毒脱落。
39名感染HIV-1的女性每季度采集血液、宫颈阴道灌洗液和宫颈活检样本,持续5年。通过Luminex检测法对宫颈阴道灌洗液中的细胞因子/趋化因子进行定量,并使用免疫组织化学对宫颈活检样本中的细胞表型进行表征。使用广义估计方程比较所有女性以及间歇性脱落HIV-1的女性亚组中非脱落和脱落访视期间细胞因子/趋化因子浓度以及T细胞组织染色阳性百分比。
当检测到血浆HIV-1时,生殖道HIV-1脱落更为常见。与细胞生长相关的细胞因子(白细胞介素-7)、Th1细胞/炎症(白细胞介素-12p70)和 fractalkine在间歇性脱落者以及所有受试者的脱落访视时与非脱落访视相比均显著增加。在间歇性脱落者以及所有受试者中,FOXP3 T细胞在脱落访视时显著减少。然而,与HIV-1脱落相关的CD8细胞和CD8FOXP3 T细胞比例显著增加。
在间歇性HIV-1脱落者中,脱落访视时FOXP3 T细胞减少表明局部HIV-1复制导致CD4 T细胞耗竭,同时CD8FOXP3细胞比例增加。HIV-1感染细胞的损失可能促进一种细胞因子环境,维持细胞稳态并增加免疫抑制细胞以应对宫颈组织中的HIV-1复制。